Achieving Global Harmonization: PV & RMP Regulatory Compliance
UBC Pharmacovigilance experts, Helena Pedrosa and Philippe Botteron presented at DIA Europe on how to achieve global harmonization of PV & RMP regulatory compliance.
UBC Participates in Rare Disease Day® at NIH 2024
UBC joined patients, researchers, and industry leaders at this year’s Rare Disease Day at NIH to discuss advancing research, improving diagnostics, and accelerating treatments for those living with rare diseases.
The Joint Clinical Assessment Affect on European Patient Access
Find out what the new Joint Clinical Assessment from the European Union could mean for accelerating patient access to innovative medicines.
Pharmacovigilance AI Best Practices: How to Apply the EU AI Act 2023
Read into the latest PV AI Best Practices, discover how to apply the EU AI Act 2023.
Podcast: Considerations for How AI Will Impact Your Brand’s Patient Services
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
FDA Finalizes Guidance On Registries’ Contributions to Regulatory Submissions
Read into the implications of the latest guidance from the FDA on registries usefulness for various purposes and how to best build one.
How to Introduce AI-Powered Analytics to Patient Services
Utilizing AI-powered analytics for your patient services data can help unlock benefits that ultimately improve patient outcomes.
Real-World Evidence Opportunities for Emerging Biotech
The use of real-world evidence has greatly expanded in recent years but is still underutilized by emerging biotechs.
KAB Surveys: Establishing a Threshold of Demonstrated Understanding
Learn more about how to utilize Knowledge, Attitude, and Behavior Surveys to evaluate stakeholders in your REMS program.
